Moberg Pharma AB (FRA:MB8) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 02, 2026)


FRA:MB8 Moberg Pharma AB FRA:MB8
60 GF Score
Price €0.80
GF Value €1.04
! 1 Warning Sign
View Full Analysis

What is Moberg Pharma AB Float Percentage Of Total Shares Outstanding?

Moberg Pharma AB FRA:MB8 -1.12% 60 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 02, 2026. GuruFocus rates FRA:MB8 with a GF Score™ of 60/100 and a GF Value™ of €1.04. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Moberg Pharma AB's float shares is 0.00 Mil. Moberg Pharma AB's total shares outstanding is 47.18 Mil. Moberg Pharma AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Moberg Pharma AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Moberg Pharma AB's Institutional Ownership is 2.68%.

FRA:MB8
60GF Score
Moberg Pharma AB FRA:MB8
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moberg Pharma AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Moberg Pharma AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/47.18
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Moberg Pharma AB (FRA:MB8) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Moberg Pharma AB and its competitors.
Is Moberg Pharma AB's Float Percentage Of Total Shares Outstanding too high?
Moberg Pharma AB's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Moberg Pharma AB has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Moberg Pharma AB's Float Percentage Of Total Shares Outstanding compare to ZTS and UTHR?
Moberg Pharma AB's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Moberg Pharma AB and its competitors. Moberg Pharma AB's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moberg Pharma AB stock overvalued right now?
Moberg Pharma AB (FRA:MB8) has a current Float Percentage Of Total Shares Outstanding of 0.00%. The stock's GF Value™ is €1.04, compared to a current price of €0.80 — trading 23.6% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Moberg Pharma AB's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Moberg Pharma AB (FRA:MB8), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moberg Pharma AB (FRA:MB8) Overvalued in 2026?

Based on GuruFocus' analysis, Moberg Pharma AB stock appears to be undervalued. The current stock price of €0.80 is trading 23.6% below its estimated GF Value™ of €1.04.

Key valuation signals for FRA:MB8:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €1.04 vs. price of €0.80 (23.6% below fair value)
  • GF Score™: 60/100 with 1 warning sign

No single metric tells the full story. See the FRA:MB8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moberg Pharma AB Business Description

Other Exchanges MBGPF:USAMOB:Sweden
Address Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company which develops and commercializes proprietary pharmaceuticals based on proven substances. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.
60GF Score

Get the complete analysis for FRA:MB8

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.80
Price
€1.04
GF Value